This systematic review and meta-analysis assesses type 2 diabetes mellitus risk associated with antipsychotic treatment in youth.
This cohort study investigates associations between striatal activity (measured via functional magnetic resonance imaging) during reward anticipation and weight change induced by amisulpride, a selective dopamine D2 receptor antagonist, among antipsychotic-naive patients with schizophrenia.
This 22-year longitudinal study reports that women with highest number of symptoms of posttraumatic stress disorder had a nearly 2-fold increased risk of type 2 diabetes mellitus over follow-up than women with no trauma exposure.
This study assesses cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders.
In a retrospective cohort study, Bobo and coauthors compare the risk of type 2 diabetes in children and youth 6 to 24 years of age for recent initiators of antipsychotic drugs vs propensity score–matched controls who had recently another psychotropic medication.
Sullivan et al determine whether comorbid depression in patients with type 2 diabetes accelerates cognitive decline.